Safety risks with gadolinium-based contrast agents

被引:4
|
作者
Marzella, Louis
Gelperin, Kate
机构
[1] US FDA, FDA Ctr Drug Evaluat & Res CDER, Off Surveillance & Epidemiol, Silver Spring, MD 20993 USA
[2] US FDA, FDA Ctr Drug Evaluat & Res CDER, Off Oncol Drug Prod, Div Med Imaging & Hematol Prod, Silver Spring, MD USA
关键词
D O I
10.1002/jmri.21021
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:816 / 816
页数:1
相关论文
共 50 条
  • [1] Response to: Safety risks with gadolinium-based contrast agents
    Maki, Jeffrey H.
    Prince, Martin R.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2007, 26 (03) : 817 - 817
  • [2] Gadolinium-based Contrast Agents: Patient Safety Concerns
    Foster-Bollman, Christy
    Mackey, Tim K.
    RADIOLOGIC TECHNOLOGY, 2016, 87 (05) : 552M - 556M
  • [3] Pharmaceutical and safety aspects of gadolinium-based contrast agents
    Sieber, Martin A.
    EJHP PRACTICE, 2009, 15 (06): : 24 - 27
  • [5] Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review
    Rudnick, Michael R.
    Wahba, Ihab M.
    Leonberg-Yoo, Amanda K.
    Miskulin, Dana
    Litt, Harold, I
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (04) : 517 - 528
  • [6] Gadolinium-based Imaging Contrast Agents
    Milic, Natasa
    Preradovic, Nikolina
    Milosevic, Natasa
    Cirilovic, Viktorija Vucaj
    Till, Viktor
    CURRENT MEDICAL IMAGING REVIEWS, 2014, 10 (02) : 140 - 150
  • [7] Gadolinium-based contrast agents and Infertility
    Cildag, Mehmet B.
    ANDROLOGIA, 2018, 50 (09)
  • [8] Extracellular gadolinium-based contrast agents
    Soler-Fernandez, R.
    Mendez-Diaz, C.
    Rodriguez-Garcia, E.
    RADIOLOGIA, 2024, 66 : S51 - S64
  • [9] Alternatives to Gadolinium-Based Contrast Agents
    Tweedle, Michael F.
    INVESTIGATIVE RADIOLOGY, 2021, 56 (01) : 35 - 41
  • [10] Gadolinium-based contrast agents in children
    Michael N. Rozenfeld
    Daniel J. Podberesky
    Pediatric Radiology, 2018, 48 : 1188 - 1196